lung-cancer

Documents about lung-cancer

• A Phase 2 Study of Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer#414496ClinicalTrials.gov
• A Trial to Learn How the Cancer Vaccine BNT116 in Combination With Cemiplimab Works and How Safe the Combination is in Adults With Advanced Non-small Cell Lung Cancer (EMPOWERVAX Lung 1)#314319ClinicalTrials.gov
• Metformin in Stage IV Lung Adenocarcinoma#383532ClinicalTrials.gov
• Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor#180192ClinicalTrials.gov
• Dataset of bronchoalveolar lavage extracellular vesicle miRNA profiles, demographic, clinical and genetic biomarkers for early lung cancer diagnostics#205099DataverseLV Dataverse OAI Archive
• Peptide Vaccine Targeting to Cancer Specific Antigen Combined With Anti-angiogenic Peptide Antigen in Treating Patients With Non-small Cell Lung Cancer#346988ClinicalTrials.gov
• Observation on the Therapeutic Effect of Huaier Granules in the Adjuvant Treatment of Non-small Cell Lung Cancer After Radical Surgery#435730ClinicalTrials.gov
• Neoantigen-primed DC Vaccines Therapy for Refractory Lung Cancer#346924ClinicalTrials.gov
• Testing of Tazemetostat in Combination With Topotecan and Pembrolizumab in Patients With Recurrent Small Cell Lung Cancer#146473ClinicalTrials.gov
• Genetically Engineered Natural Killer (NK) Cells With or Without Atezolizumab for the Treatment of Non-small Cell Lung Cancer Previously Treated With PD-1 and/or PD-L1 Immune Checkpoint Inhibitors#121363ClinicalTrials.gov
• Similar Efficacy, Safety, and Immunogenicity of FYB206 in Comparison to Keytruda as add-on to Chemotherapy in Patients With Non-squamous Non-small Cell Lung Cancer (NSCLC)#287528ClinicalTrials.gov
• A Study of Mycobacterium w in Combination With Paclitaxel Plus Cisplatin in Advanced Non Small Cell Lung Cancer#154718ClinicalTrials.gov
• Salvage Therapy With Sunitinib,Docetaxel and Platinum on Metastatic or Unresectable Non Small Cell Lung Cancer#160349ClinicalTrials.gov
• Pseudohypoxia induced by iron chelator activates tumor immune response in lung cancer#194773OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Tariquidar and Docetaxel to Treat Patients With Lung, Ovarian, Renal and Cervical Cancer#208474ClinicalTrials.gov
• A Study of Anti-PD-1 AK105 in Patients With Metastatic Nonsquamous Non-small Cell Lung Cancer#217019ClinicalTrials.gov
• Association Between Circulating Immune Cells and the Tumor Immune Contexture in Resectable Non-small Cell Lung Cancer#245506ClinicalTrials.gov
• Tumor Growth Rate (TGR) Predicts Clinical Outcomes for Advanced Non-small Cell Lung Cancer Undergoing Immunotherapy.#256868ClinicalTrials.gov
• Cryoablation with or Without Serplulimab in Treating Patients with Stage I-IIA Non-small Cell Lung Cancer#307444ClinicalTrials.gov
• TGF-β Inhibitor Potentiates Osimertinib-Induced Anti-Tumor Immunity in Egfr-Mutant Lung Cancer#309399OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Short-term Effects of Osteopathic Manipulations on Heart Rate Variability in Lung Cancer Patients - A Randomized Pilot Study#325278ClinicalTrials.gov
• A Study Evaluating Neoadjuvant Chemoimmunotherapy With Immunosensitizing Radiation for Borderline Resectable Non-Small Cell Lung Cancer#356468ClinicalTrials.gov
• Efficacy and Safety of Immunotherapy in Non-small Cell Lung Cancer With Uncommon Histological Type#363599ClinicalTrials.gov
• Lamivudine in Combination With Chemoimmunotherapy for the Treatment of Extensive Stage Small Cell Lung Cancer#373583ClinicalTrials.gov
• Trial of RNActive®-Derived Cancer Vaccine and Local Radiation in in Stage IV Non Small Cell Lung Cancer (NSCLC)#390974ClinicalTrials.gov
• Adebrelimab Combined With Chemotherapy and Concurrent SBRT for Neoadjuvant Treatment of Limited-stage Small Cell Lung Cancer#230404ClinicalTrials.gov
• TEAS for the Treatment of Pain in Bone Metastases of Lung Cancer#407718ClinicalTrials.gov
• Lung-MAP S1400K: c-MET Positive#444873ClinicalTrials.gov
• Sleep State in Lung Cancer: A Retrospective Analysis#407723ClinicalTrials.gov
• Personalized DC Vaccine for Postoperative Cancer#141079ClinicalTrials.gov
• Evaluation for NCI Surgery Branch Clinical Research Protocols#152401ClinicalTrials.gov
• Testing the Addition of an Anti-cancer Drug, Berzosertib (M6620, VX-970), to the Usual Treatments (Carboplatin and Gemcitabine) and to Pembrolizumab for Patients With Advanced Squamous Cell Non-small Cell Lung Cancer#245492ClinicalTrials.gov
• Brodalumab in the Treatment of Immune-Related Adverse Events#346915ClinicalTrials.gov
• Real-World Outcomes of First-Line Nivolumab + Ipilimumab With Chemotherapy in Non-Small Cell Lung Cancer in Poland#143541ClinicalTrials.gov
• Perioperative Immunotherpay Versus Adjuvant Immunotherapy for Resectable Non-small Cell Lung Cancer#311132ClinicalTrials.gov
• Chemo-Immunotherapy Followed by Durvalumab and Ceralasertib in Treatment Naïve Patients With Extensive Stage Small Cell Lung Cancer#314337ClinicalTrials.gov
• Delineation of lung cancer with FDG PET/CT during radiation therapy#315133HAL (France)
• Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer#321704ClinicalTrials.gov
• Carbon Ion Radiotherapy for Locally Advanced Lung Cancer in Elderly Patients#353282ClinicalTrials.gov
• A Phase II Study of QL1706 With Anti-angiogenesis Therapy and Chemotherapy in Extensive-stage Small Cell Lung Cancer.#356463ClinicalTrials.gov
• Atezolizumab After Concurrent Chemo-radiotherapy Versus Chemo-radiotherapy Alone in Limited Disease Small-cell Lung Cancer#398317ClinicalTrials.gov
• Tislelizumab Combined With Recombinant Human Endostatin Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung Cancer.#432890ClinicalTrials.gov
• Evaluation of Lymph Node Analysis Using One Step Nucleic Acid Amplification (OSNA) in Patients With Lung Cancer Who Underwent Robotic Lung Resection, Comparison With Traditional Methods#373608ClinicalTrials.gov
• A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)#390902ClinicalTrials.gov
• Vaccine Therapy and Biological Therapy in Treating Patients With Advanced Cancer#146250ClinicalTrials.gov
• The landscape of lung cancer screening globally: a comparison of established programs and estimates of eligibility to participate#205470Europe PMC
• MOLECULAR DETERMINANTS OF EGFR DEPENDENCE IN LUNG ADENOCARCINOMA#242090ScholarBank@NUS
• CCCR-NK92 Cells Immunotherapy for Non-small Cell Lung Carcinoma#346917ClinicalTrials.gov
• Serplulimab for Patients With Non-small Cell Lung Cancer (NSCLC) With TPS ≥ 50%: a Prospective, Single-center, Single-arm Phase 2 Study.#162488ClinicalTrials.gov
• Air pollution and the risk of second primary lung cancer among lung cancer survivors: the prospective UK Biobank cohort study#323997Springer Nature OA